Adverse Drug Event Reporting: The Roles of Consumers and Health-Care Professionals: Workshop Summary

Print

Cover Image

PAPERBACK
$21.00

Download

Table of Contents
Front Matter R1-R12
Summary 1-6
1 Introduction 7-11
2 Current Adverse Event Reporting Systems 12-17
3 Active Surveillance Systems 18-25
4 Consumer Involvement in Reporting Adverse Events 26-33
5 Drug-Drug Interactions 34-39
6 Drug Labels 40-47
References 48-52
A Workshop Agenda 53-57
B Speaker Biographies 58-70

View/Hide Left Panel

	Rachel E. Behrman, MD, MPH U.S. Food and Drug Administration
	Ed Staffa, RPh National Association of Chain Drug Stores
	Cary Sennett, MD, PhD American Board of Internal Medicine
10:40 am	Discussion
11:00 am	Break

Topic 3: Are there electronic systems that can be used to prompt health care providers to look for adverse drug related events and warn against potential drug-drug interactions? How are these systems deployed?

11:15 am	Peter Kilbridge, MD Duke University Health System
	Stuart Levine, PharmD Institute for Safe Medication Practices
11:40 am	Discussion
12:00 pm	Next Steps for the IOM Drug Forum
12:30 pm	Adjourn

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement